Ultrasound/Imaging
Poster Session 1
Keisuke Akita, MD
Keio University School of Medicine
Shinjuku-ku, Tokyo, Japan
Satoru Ikenoue, MD.PhD
Keio University School of Medicine
Tokyo, Tokyo, Japan
Junko Tamai, MD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Keita Hasegawa, MD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Kaoru Kajikawa, MD
Keio University School of Medicine
Tokyo, Tokyo, Japan
Marina Takahashi, MD
Keio University School of Medicine
Tokyo, Tokyo, Japan
Kunio Tanaka, MD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Yuka Fukuma, MD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Yuya Tanaka, MD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Toshimitsu Otani, MD, PhD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Yoshifumi Kasuga, MD, PhD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Mamoru Tanaka, MD, PhD
Keio University School of Medicine
Shinanomachi, Tokyo, Japan
Insulin-like growth factor-1 (IGF-1) is one of the growth factors that promote protein and carbohydrate metabolism, and consequently affects birth weight. Fetal fractional thigh volume has been proposed as a useful parameter for predicting birth weight and quantifying fetal soft tissue development. However, the association between maternal serum IGF-1 and fetal fractional thigh volume remains unclear. This study aimed to investigate the association of maternal serum insulin-like growth factor-1 and fetal fractional thigh volume.
Study Design:
A prospective study was conducted in a cohort of 24 singleton pregnancies. Maternal blood sample was obtained at 24 weeks’ gestation, and fetal ultrasonography was performed at 24-, 30-, and 36-weeks’ gestation. Fractional thigh volume was assessed as cylindrical limb volumes based on 50% of the fetal total diaphysis length using 3D ultrasonography. The association between maternal serum IGF-1 and fetal fractional thigh volume was examined using Pearson product moment correlations.
Results:
Maternal serum IGF-1 at 24 weeks was 140.0±5.7 ng/ml (mean±S.E.). Maternal IGF-1 was not associated with fetal fractional thigh volume at 24 weeks (r = 0.016, p = 0.930) and 30 weeks (r = 0.229, p = 0.216). Maternal IGF-1 significantly correlated with fetal fractional thigh volume at 36 weeks (r = 0.475, p = 0.019).
Conclusion:
Maternal serum IGF-1 at 24 weeks significantly correlated with fetal fractional thigh volume in late gestation. Maternal serum IGF-1 in mid-gestation could be a marker for predicting fetal growth in late gestation.